Ownership history in Bayesian Capital Management, LP · 11 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in REPLIGEN CORP (RGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,948 | +882 | +42.7% | 0.08% | $394K | $133.67 |
| 2025 Q1 | REDUCED | 2,066 | -4,512 | -68.6% | 0.04% | $263K | $127.24 |
| 2024 Q4 | ADDED | 6,578 | +3,778 | +134.9% | 0.12% | $947K | $143.94 |
| 2024 Q1 | ADDED | 2,800 | +1,638 | +141.0% | 0.05% | $515K | $183.92 |
| 2023 Q4 | REDUCED | 1,162 | -4,380 | -79.0% | 0.02% | $209K | $179.80 |
| 2023 Q1 | ADDED | 5,542 | +567 | +11.4% | 0.12% | $933K | $168.36 |
| 2022 Q4 | ADDED | 4,975 | +4,089 | +461.5% | 0.12% | $842K | $169.31 |
| 2021 Q4 | REDUCED | 886 | -2,114 | -70.5% | 0.07% | $235K | $264.84 |
| 2021 Q1 | REDUCED | 3,000 | -2,100 | -41.2% | 0.13% | $583K | $194.41 |
| 2020 Q4 | REDUCED | 5,100 | -1,213 | -19.2% | 0.26% | $977K | $191.63 |
As of 2025 Q4 — sorted by position size